Copyright
©2014 Baishideng Publishing Group Co.
World J Meta-Anal. Feb 26, 2014; 2(1): 1-16
Published online Feb 26, 2014. doi: 10.13105/wjma.v2.i1.1
Published online Feb 26, 2014. doi: 10.13105/wjma.v2.i1.1
Table 2 Risk of cardiac events according to different combinations of heart-to-mediastinum ratio, left ventricular ejection fraction, and β-type natriuretic peptide
| Risk level | Predictors combination |
| Very high | H/M ratio < 1.6 |
| LVEF < 30% | |
| BNP > 140 ng/L | |
| High | H/M ratio < 1.6 |
| LVEF ≥ 30% | |
| BNP ≤ 140 ng/L | |
| Low | H/M ratio ≥ 1.6 |
| LVEF < 30% | |
| BNP > 140 ng/L | |
| Very low | H/M ratio ≥ 1.6 |
| LVEF ≥ 30% | |
| BNP ≤ 140 ng/L |
- Citation: Petretta M, Petretta A, Pellegrino T, Nappi C, Cantoni V, Cuocolo A. Role of nuclear cardiology for guiding device therapy in patients with heart failure. World J Meta-Anal 2014; 2(1): 1-16
- URL: https://www.wjgnet.com/2308-3840/full/v2/i1/1.htm
- DOI: https://dx.doi.org/10.13105/wjma.v2.i1.1